Unknown

Dataset Information

Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers.


ABSTRACT: Preeclampsia is a pregnancy-specific syndrome that causes substantial maternal and fetal morbidity and mortality. The etiology is incompletely understood, and there is no clinically useful screening test. Current metabolomic technologies have allowed the establishment of metabolic signatures of preeclampsia in early pregnancy. Here, a 2-phase discovery/validation metabolic profiling study was performed. In the discovery phase, a nested case-control study was designed, using samples obtained at 15±1 weeks' gestation from 60 women who subsequently developed preeclampsia and 60 controls taking part in the prospective Screening for Pregnancy Endpoints cohort study. Controls were proportionally population matched for age, ethnicity, and body mass index at booking. Plasma samples were analyzed u

SUBMITTER: Kenny LC 

PROVIDER: S-EPMC7614124 | biostudies-literature | 2010 Oct

REPOSITORIES: biostudies-literature